Romano Sarah 4
4 · First Wave BioPharma, Inc. · Filed Mar 2, 2022
Insider Transaction Report
Form 4
Romano Sarah
Chief Financial Officer
Transactions
- Award
Stock option (right to buy)
2022-03-01+150,000→ 150,000 totalExercise: $1.18Exp: 2032-03-01→ Common stock, par value $0.0001 per share (150,000 underlying)
Footnotes (1)
- [F1]The stock option vests in three equal annual installments commencing on March 1, 2023.